Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study
2006

Study of Antibodies in Kidney Disease

Sample size: 86 publication 10 minutes Evidence: moderate

Author Information

Author(s): Marjan C Slot, Ruud Theunissen, Pieter van Paassen, Jan GMC Damoiseaux, Jan Willem Cohen Tervaert

Primary Institution: Dept. of Clinical and Experimental Immunology, university hospital Maastricht

Hypothesis

Infections may trigger the ANCA response against MPO through hHSP60.

Conclusion

Antibodies against mHSP65 are higher in AAV compared to healthy controls, and anti-hHSP60 antibodies are higher in patients with MPO-ANCA than in patients with PR3-ANCA and healthy controls.

Supporting Evidence

  • Anti-mHSP65 levels were significantly higher in AAV compared to healthy controls.
  • Anti-hHSP60 levels were significantly higher in MPO-ANCA compared to PR3-ANCA and healthy controls.
  • No correlation was found between MPO-ANCA and anti-hHSP60 levels.

Takeaway

This study looked at patients with kidney disease and found that certain antibodies are higher in those with a specific type of kidney problem, suggesting infections might play a role.

Methodology

Antibodies were measured in patients with ANCA-associated vasculitis using ELISA and compared to healthy controls.

Potential Biases

Potential bias due to the selection of patients from a single center.

Limitations

The study was retrospective and had a limited sample size.

Participant Demographics

Mean age of participants was 62.2 years, with 69% male.

Statistical Information

P-Value

0.003

Confidence Interval

95% CI 1.9 – 124

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1740-2557-3-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication